www.antena3.ro/economic/companii/de-ce-apreciem-ma

Richard Saynor, CEO of Sandoz, warns that Europe's reliance on antibiotics from China threatens essential medicine supply security. He calls for fair competition conditions for European producers and highlights the need for funding to maintain production in Europe. Sandoz, one of the last antibiotic manufacturers in Europe, faces strong competition from China, which supplies 86% of the EU's penicillin imports. Saynor emphasizes the importance of local production for public health and security, arguing that low antibiotic prices do not reflect their value. He advocates for the Critical Medicines Act to improve medicine availability and production in Europe, while also addressing the need for equitable pricing in healthcare.